CIRC(01763) has pioneered the key raw material technology for exhaled diagnosis, becoming a leading enterprise with complete control over the entire industry chain of exhaled testing products.

CIRC (01763) issued an announcement on October 31st, stating that the release of carbon isotope products marks a breakthrough in high-end technology in the field of stable isotopes in China, solving the bottleneck problem. With the ability to produce high abundance 13CO gas and carbon 13 urea raw materials, China has become one of the few countries in the world with this capability. High abundance 13CO gas is a key raw material used in the urea breath test to detect Helicobacter pylori infection. The official release of this product signifies that CIRC has broken the dependency on imported 13CO raw materials for the urea breath test in China, significantly enhancing the research and production technology capabilities in stable isotopes. This marks a step towards China's research and application of stable isotope technology leading the world, with CIRC becoming a leading enterprise in mastering the full industry chain of breath test products. On that day, CIRC officially launched the construction of the second phase of the stable isotope base project. Upon completion, CIRC will have the capability to provide stable supply of high abundance 13CO gas, carbon 13 urea raw materials, and other raw materials for drugs used in the treatment of gastrointestinal diseases. This is important for improving the national health level, promoting the high-quality development of medical isotopes, and serving the construction of a "Healthy China."